# Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)

> **NCT01254318** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 130 (actual)

## Conditions studied

- Mycoses
- Leukemia

## Interventions

- **OTHER:** Standard Care

## Key facts

- **NCT ID:** NCT01254318
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2016-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01254318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01254318, "Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01254318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*